List of Excipients in API DEXLANSOPRAZOLE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing DEXLANSOPRAZOLE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| TWI PHARMACEUTICALS INC | DEXLANSOPRAZOLE | dexlansoprazole | 24979-703 | ALUMINUM OXIDE | |
| TWI PHARMACEUTICALS INC | DEXLANSOPRAZOLE | dexlansoprazole | 24979-703 | CARRAGEENAN | |
| TWI PHARMACEUTICALS INC | DEXLANSOPRAZOLE | dexlansoprazole | 24979-703 | FD&C BLUE NO. 2 | |
| TWI PHARMACEUTICALS INC | DEXLANSOPRAZOLE | dexlansoprazole | 24979-703 | FERRIC OXIDE RED | |
| TWI PHARMACEUTICALS INC | DEXLANSOPRAZOLE | dexlansoprazole | 24979-703 | HYDROXYPROPYL CELLULOSE | |
| TWI PHARMACEUTICALS INC | DEXLANSOPRAZOLE | dexlansoprazole | 24979-703 | HYPROMELLOSE | |
| TWI PHARMACEUTICALS INC | DEXLANSOPRAZOLE | dexlansoprazole | 24979-703 | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing DEXLANSOPRAZOLE
Detailed excipient profiles for DEXLANSOPRAZOLE
Excipient focus: ALUMINUM OXIDE
DEXLANSOPRAZOLE drug variants containing ALUMINUM OXIDE
DEXLANSOPRAZOLE drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIA
DEXLANSOPRAZOLE drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2244 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing AMMONIA
Excipient focus: BUTYL ALCOHOL
DEXLANSOPRAZOLE drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2244 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing BUTYL ALCOHOL
Excipient focus: CALCIUM HYDROXIDE
DEXLANSOPRAZOLE drug variants containing CALCIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2244 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing CALCIUM HYDROXIDE
Excipient focus: CARRAGEENAN
DEXLANSOPRAZOLE drug variants containing CARRAGEENAN
DEXLANSOPRAZOLE drug variants not containing CARRAGEENAN
Excipient focus: D&C YELLOW NO. 10
DEXLANSOPRAZOLE drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2239 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing D&C YELLOW NO. 10
Excipient focus: ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B
DEXLANSOPRAZOLE drug variants containing ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B
Excipient focus: FD&C BLUE NO. 1
DEXLANSOPRAZOLE drug variants containing FD&C BLUE NO. 1
DEXLANSOPRAZOLE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
DEXLANSOPRAZOLE drug variants containing FD&C BLUE NO. 2
DEXLANSOPRAZOLE drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2244 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
DEXLANSOPRAZOLE drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2239 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 5
DEXLANSOPRAZOLE drug variants containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing FD&C YELLOW NO. 5
Excipient focus: FD&C YELLOW NO. 6
DEXLANSOPRAZOLE drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
DEXLANSOPRAZOLE drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| A-S Medication Solutions | dexlansoprazole | 50090-5956 |
| Physicians Total Care Inc | dexlansoprazole | 54868-5998 |
| Takeda Pharmaceuticals America Inc | dexlansoprazole | 64764-171 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERROSOFERRIC OXIDE
DEXLANSOPRAZOLE drug variants containing FERROSOFERRIC OXIDE
DEXLANSOPRAZOLE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GLYCERYL MONO AND DIPALMITOSTEARATE
DEXLANSOPRAZOLE drug variants containing GLYCERYL MONO AND DIPALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing GLYCERYL MONO AND DIPALMITOSTEARATE
Excipient focus: HYDROXYPROPYL CELLULOSE
DEXLANSOPRAZOLE drug variants containing HYDROXYPROPYL CELLULOSE
DEXLANSOPRAZOLE drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2239 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
DEXLANSOPRAZOLE drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | dexlansoprazole | 54868-5998 |
| Physicians Total Care Inc | dexlansoprazole | 54868-6152 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: HYPROMELLOSE
DEXLANSOPRAZOLE drug variants containing HYPROMELLOSE
DEXLANSOPRAZOLE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
DEXLANSOPRAZOLE drug variants containing HYPROMELLOSE 2910
DEXLANSOPRAZOLE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
DEXLANSOPRAZOLE drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| Physicians Total Care Inc | dexlansoprazole | 54868-6152 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
DEXLANSOPRAZOLE drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2244 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LAURYL SULFATE
DEXLANSOPRAZOLE drug variants containing LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2244 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing LAURYL SULFATE
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
DEXLANSOPRAZOLE drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
DEXLANSOPRAZOLE drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Excipient focus: MAGNESIUM CARBONATE
DEXLANSOPRAZOLE drug variants containing MAGNESIUM CARBONATE
DEXLANSOPRAZOLE drug variants not containing MAGNESIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2244 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
DEXLANSOPRAZOLE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2244 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing MANNITOL
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
DEXLANSOPRAZOLE drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
DEXLANSOPRAZOLE drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
DEXLANSOPRAZOLE drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
DEXLANSOPRAZOLE drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| Physicians Total Care Inc | dexlansoprazole | 54868-5998 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
DEXLANSOPRAZOLE drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| Takeda Pharmaceuticals America Inc | dexlansoprazole | 64764-171 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Excipient focus: METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
DEXLANSOPRAZOLE drug variants containing METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
Excipient focus: POLYETHYLENE GLYCOL
DEXLANSOPRAZOLE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2244 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 6000
DEXLANSOPRAZOLE drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2239 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
DEXLANSOPRAZOLE drug variants containing POLYETHYLENE GLYCOL 8000
DEXLANSOPRAZOLE drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYSORBATE 80
DEXLANSOPRAZOLE drug variants containing POLYSORBATE 80
DEXLANSOPRAZOLE drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
DEXLANSOPRAZOLE drug variants containing POTASSIUM CHLORIDE
DEXLANSOPRAZOLE drug variants not containing POTASSIUM CHLORIDE
Excipient focus: POTASSIUM HYDROXIDE
DEXLANSOPRAZOLE drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
DEXLANSOPRAZOLE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing POVIDONE
Excipient focus: PROPYLENE GLYCOL
DEXLANSOPRAZOLE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| ENDO USA Inc | dexlansoprazole | 49884-148 |
| REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2244 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
DEXLANSOPRAZOLE drug variants containing SHELLAC
DEXLANSOPRAZOLE drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
DEXLANSOPRAZOLE drug variants containing SILICON DIOXIDE
DEXLANSOPRAZOLE drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2239 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
DEXLANSOPRAZOLE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
| A-S Medication Solutions | dexlansoprazole | 50090-6514 |
| Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
| Bryant Ranch Prepack | dexlansoprazole | 72162-2239 |
| >Company | >Ingredient | >NDC |
DEXLANSOPRAZOLE drug variants not containing SODIUM HYDROXIDE
Excipient focus: STARCH, CORN
DEXLANSOPRAZOLE drug variants containing STARCH, CORN
DEXLANSOPRAZOLE drug variants not containing STARCH, CORN
Excipient focus: SUCROSE
DEXLANSOPRAZOLE drug variants containing SUCROSE
DEXLANSOPRAZOLE drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
DEXLANSOPRAZOLE drug variants containing TALC
DEXLANSOPRAZOLE drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
DEXLANSOPRAZOLE drug variants containing TITANIUM DIOXIDE
DEXLANSOPRAZOLE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
DEXLANSOPRAZOLE drug variants containing TRIETHYL CITRATE
DEXLANSOPRAZOLE drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
